abstract |
The present invention relates to compounds of formula (I), pharmaceutical compositions comprising these compounds and their use as PARP inhibitors:n n n n n n n n Wheren n n R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and X have the meanings defined in the specification. |